Smart cancer nanomedicine
Roy van der Meel(University of British Columbia), Twan Lammers(Integrated Oncology (United States))
Cited by 1,182
Related Papers
Tumor targeting via EPR: Strategies to enhance patient responses
|Advanced Drug Delivery Reviews|2018|1.2k
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
|Nucleic Acid Therapeutics|2018|539
Tumour-targeted nanomedicines: principles and practice
|British Journal of Cancer|2008|535
Core-crosslinked polymeric micelles: Principles, preparation, biomedical applications and clinical translation
|Nano Today|2015|499
Histopathological biomarkers for predicting the tumour accumulation of nanomedicines
|Nature Biomedical Engineering|2024|43